KR20170013649A - System and Method for Evaluation of Brain Function and Recommendation for personalized brain wellness - Google Patents

Abstract

The present invention relates to a system and a method for evaluating brain function. The system for evaluating the brain function according to one aspect of the present invention comprises: a biometric information obtaining unit which obtains a brain wave signal from a brain part of a subject; a brain wave analyzing unit which compares brain wave information corresponding to the obtained brain wave signal with preset reference brain wave information to analyze whether there is insufficient neurotransmitter among the neurotransmitters of the subject; and a comprehensive evaluation unit which generates a solution recommendation result including an undrugged first prescription capable of controlling the amount of insufficient neurotransmitter secretion if there is insufficient neurotransmitter.

Description

TECHNICAL FIELD [0001] The present invention relates to a wellness recommendation system for evaluating and promoting brain function,

TECHNICAL FIELD The present invention relates to a brain function evaluation technique, and more particularly, to a wellness recommendation system and an implementation method for evaluation and promotion of brain function using brain waves and pulse waves.

Electroencephalogram (EEG) is a kind of biological wave that life produces, and human brain waves appear as a kind of voltage change in the scalp area of the human body. Generally, the brain waves appear in an amplitude of a voltage range of 10 to 200 mu V in the frequency range of approximately 0 to 60 Hz. The brain waves of the human body are divided into gamma wave (gamma wave), alpha wave (alpha wave), beta wave (beta wave), delta wave (delta wave), and theta wave (? Wave) according to the range of the frequency.

The delta wave is an EEG less than 4Hz and occurs mainly in the sleep state. Theta wave is in the range of 4 ~ 8Hz, mainly in the blunt state. The alpha wave is an EEG with frequency of 8 ~ 13Hz and occurs mainly in a stable state. And the Kobe beat is an EEG at a frequency of 25 Hz, which occurs mainly when it is excited or stressed.

As described above, various EEGs can be generated depending on the state of arousal of the human body and the degree of psychological stability, so various devices for analyzing the state of the human body by analyzing brain waves are under research and development.

Korean Registered Patent No. 10-1218618 (December 28, 2012)

SUMMARY OF THE INVENTION It is an object of the present invention to provide a wellness recommendation system and method for evaluating and enhancing brain function capable of evaluating the adequacy of the amount of neurotransmitter secretion using brain waves .

The objects of the present invention are not limited to the above-mentioned objects, and other objects not mentioned can be clearly understood by those skilled in the art from the following description.

A brain function evaluation system according to an aspect of the present invention includes: a biological information acquirer for acquiring an EEG signal from a brain region of a subject; An EEG analyzer for comparing EEG information corresponding to the acquired EEG signal with predetermined EEG information to analyze whether there is a deficient neurotransmitter among the neurotransmitters of the subject; And a comprehensive evaluator for generating a solution recommendation result sheet including a non-pharmacological first prescription that can control the secretion amount of the neurotransmitter to be administered, if the insufficient neurotransmitter is present as a result of the analysis.

A method for evaluating brain function by a brain function evaluating apparatus according to another aspect of the present invention is a method for evaluating brain function by means of a brain function evaluating apparatus for examining at least one of cognition, brain characteristics, eating habits, Sequentially providing pages; Guiding the necessity of EEG measurement through the terminal if there is a symptom related to deficiency or excess secretion of neurotransmitters of the subject as a result of the test through the web page; Receiving an EEG signal obtained from the brain region of the subject as a result of the precision evaluation of the subject from the terminal of the terminal or the EEG signal; Analyzing whether there is a deficient neurotransmitter among the neurotransmitters of the subject by comparing brain wave information corresponding to the brain wave signal with predetermined reference brain wave information; And generating a solution recommendation result including a non-pharmacological first prescription that can control the secretion amount of the deficient neurotransmitter if the deficient neurotransmitter is present as a result of the analysis, and providing the solution recommendation result to the terminal .

According to the present invention, it is possible to evaluate the adequacy of the secretion amount of the neurotransmitter.

In the present invention, a personalized wellness enhancement solution capable of eliminating the imbalance of the neurotransmitter can be recommended.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1A and FIG. 1B are block diagrams showing a brain function evaluation system according to an embodiment of the present invention.
2 is a view showing an evaluation result sheet according to an embodiment of the present invention;
Figures 3a and 3b illustrate a survey according to one embodiment of the present invention.
FIG. 4 is a diagram illustrating a recommendation result of a brain health promotion solution according to an embodiment of the present invention. FIG.
FIG. 5 is a block diagram illustrating a brain function evaluation system according to another embodiment of the present invention. FIG.
FIG. 6 is a flowchart illustrating a brain function evaluation method according to another embodiment of the present invention. FIG.
Figure 7 illustrates an exemplary computing environment in which one or more embodiments disclosed herein may be implemented;

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Reference will now be made in detail to embodiments of the present invention, examples of which are illustrated in the accompanying drawings. FIGS. 1A and 1B are views showing a brain function evaluation system according to an embodiment of the present invention. FIG. 2 is a diagram showing an evaluation result sheet according to an embodiment of the present invention. FIG. 4 is a diagram illustrating a recommendation result of a brain health promotion solution according to an embodiment of the present invention. FIG. 7 is a diagram illustrating an exemplary computing environment in which one or more embodiments disclosed herein may be implemented.

1A, a brain function evaluation system 10 according to an embodiment of the present invention includes a subject information acquirer 145, a bio-information acquirer 110, a user interface 120, an autonomic neuropserver 130, a brain wave analyzer 140, a brain matrix estimator 170, a cognitive appraisal evaluator 150, a eating habit analyzer 160, a symptom evaluator 180, a comprehensive evaluator 190 and a database 200 do. Here, it goes without saying that the database 200 may not be included in the brain function evaluation system 10. Items that can be tested in response to the displayed screen such as the dietary habit analyzer 160, the brain matrix estimator 170, the cognitive appraisal evaluator 150, and the symptom evaluator 180 are measured by an examiner (not shown) Lt; / RTI > 1B, the brain function evaluation system 10 'according to an embodiment of the present invention includes a first device for performing the paper evaluation and a second device for analyzing the EEG and the autonomic nerve It is possible. In this case, the first device may guide the necessity of brain wave measurement to the person predicted as a risk group as a result of the paper evaluation. The concrete implementation thereof will be described later with reference to Figs. 5 and 6. Fig.

The subject information acquiring unit 145 receives the age of the subject through the user interface 120 and provides the information to the electroencephalograph analyzer 140, the autonomic nerve analyzer 130, and the cognitive performance evaluator 150. In addition, the subject person information acquirer 145 can collect other personal information such as the subject name, sex, residence, nationality, and the like. Alternatively, the subject person information acquirer 145 may store the subject person's personal information in the database 200. [

The database 200 is a solution for enhancing brain health (brain-health promoting personalized wellness recommendation solution, No. 1) for each age of the reference EEG index, cognitive power reference value, reference pulse wave index, cognitive test, Prescription) and autonomic balance solution (second prescription).

Here, the reference EEG index is generated by synthesizing (e.g., averaging) brain wave information of a plurality of people who are evaluated as having a healthy body and mind. The reference EEG index includes a reference brain wave of each age group Wave,? Wave,? Wave, etc.) power, frequency, and connectivity. In addition, EEG information may be different for different races at the same age, so the EEG index may be an EEG indicator corresponding to the subject's race (or nationality or state of living). In the following description, the reference EEG index is the reference EEG power as an example.

The cognitive power reference value may be at least one of the language memory, the visual memory, the reasoning ability, the execution function, and the reaction speed. For example, the age-based cognitive ability reference value may be determined by totaling statistics of at least one cognitive ability test for a plurality of testees.

At this time, the brain health improving solution may be provided for each neurotransmitter, and may include a prescription capable of promoting the synthesis of each neurotransmitter. In addition, the brain health improving solution may further include a prescription capable of inhibiting secretion of a neurotransmitter.

The user interface 120 includes at least one display means and a keypad (or mouse) to which the subject can operate.

At this time, the user interface 120 may receive a test question or a video image according to an instruction of at least one component of the brain matrix evaluator 170, the cognitive evaluator 150, the eating habit analyzer 160 and the symptom evaluator 180 And transmits the operation of the corresponding user to at least one component.

In addition, the user interface 120 can display the generated result pages (brain health promotion solution recommendation result, evaluation result sheet, opinion report, etc.) through display means, print, or the like.

The bio-information acquiring unit 110 includes at least one of a cardiac information acquiring unit for measuring cardiac information and an EEG information acquiring unit for measuring EEG information. For example, the biometric information obtaining unit 110 may be a portable terminal or a fixed terminal. Hereinafter, the cardiac information obtaining unit and the brain wave information obtaining unit will be described.

The cardiac information acquiring unit may be a sensor for measuring cardiac information of a subject such as a pulse measuring instrument, a PPG sensor, an electrocardiogram (ECG) sensor, and the like. Herein, the cardiac information refers to information on cardiac activity, and may include, for example, pulse information, photoplethysmograph (PPG) information, and electrocardiography (ECG) information. At this time, the pulse is a periodic wave generated when the blood coming from the heart touches the wall of the artery, and the pulse information can include the waveform information about the wave. For example, the pulse information may include information such as a pulse rate, an amplitude of a pulse waveform, a period of a pulse waveform, a change in a pulse waveform period, a frequency of a pulse waveform, and a rate at which a pulse width varies. In the following description, for convenience of explanation, the cardiac information is a heart rate variability (HRV) measured from an ECG or PPG signal as an example. HRV information includes SDNN, LF, HF, LF / HF, and cardiac rhythm. In the following description, the case where the reference pulse wave index is pulse wave power will be described as an example.

The EEG information acquiring unit is installed in a plurality of brain regions (for example, 19) of the subject and measures at least one of EEG (Electroencephalogram) and event-related event-related potential (ERP) And a device for storing the amplified signal. Here, the EEG (waveform) is a waveform generated by extracting or amplifying the electric current caused by the activity of the brain, and the EEG information may include amplitude of the EEG waveform, frequency information of the EEG waveform, and the like. Hereinafter, the case where the EEG information is at least one of a plurality of EEG signals and a plurality of event-related EEG signals (ERP) measured in a plurality of brain regions of the subject for a predetermined measurement time (for example, 10 minutes) For example,

Meanwhile, the cardiac information acquiring unit and the brain wave information acquiring unit may acquire cardiac information and brain wave information from different apparatuses through predetermined wireless / wired communication schemes, respectively, instead of sensing means.

The brain temperament evaluator 170 evaluates the subject's brain temperament through a questionnaire, analyzes the brain characteristics of the subject by analyzing the subject's responses to the brain temperament evaluation through the user interface 120 .

Here, the evaluation of the brain substrate confirms whether any of the neurotransmitters such as GABA, acetylcholine, dopamine and serotonin, that is, the characteristics (for example, personality characteristics, behavioral characteristics, etc.) As a question, you can even include questions about the properties that correspond to each neurotransmitter. For example, the question of confirming whether a subject has an excess secretory characteristic of GABA may be a question that confirms whether the subject has a relatively high stability, consistency or organizational harmony.

In detail, the brain matrix estimator 170 calculates the total score of the brain matrix corresponding to each neurotransmitter using a positive or an unfavorable ratio to each of the questions that inquire whether it has characteristics corresponding to each neurotransmitter can do.

At this time, the brain matrix estimator 170 generates a brain matrix (see 260 in FIG. 2) having vertices of GABA, acetylcholine, dopamine, and serotonin using the total score of the brain matrix, .

Alternatively, the brain matrix estimator 170 may transmit the total score information of the brain matrix or the brain matrix quadrangle information used for generating the matrix of the matrix to the comprehensive evaluator 190. Hereinafter, for the sake of convenience of explanation, an example will be described in which the brain tone estimator 170 provides the total score information of the brain matrix to the global tone estimator 190 as an example.

The cognitive power estimator 150 provides a video or character for testing the cognitive ability of at least one of visual memory, word memory, and numerical memory through the user interface 120 and provides a response (memory degree, etc.) And the cognitive ability of the subject is evaluated.

Specifically, the cognitive performance evaluator 150 can evaluate the visual memory by exposing the visual memory to a plurality of images, such as pictures and figures, and confirming the degree of memory for each image of the subject. Further, the cognitive performance evaluator 150 can evaluate the visual memory ability by displaying a plurality of words and confirming the degree of memory of a plurality of words of the subject. Alternatively, the cognitive power estimator 150 can evaluate the numerical memory ability by displaying at least one digit and confirming the degree of memory of the subject with respect to the displayed digit.

Here, the cognitive performance evaluator 150 may calculate the cognitive power percentage (relative cognitive power of the subject) of the subject using the cognitive ability standard value for each age in the database 200. [

Further, the cognitive power estimator 150 can further confirm the reasoning power, execution function, processing speed, and the like.

At this time, the cognitive performance evaluator 150 may display the cognitive performance information of the evaluated subject directly through the user interface 120 or may provide it to the comprehensive evaluator 190.

The eating habit analyzer 160 provides a plurality of food habit assessment statements for confirming the foods consumed by the subject and the intake amount through the user interface 120 and confirms the responses to the provided plurality of food habit evaluation statements to analyze the eating habit of the subject do. As a result, the eating habit analyzer 160 calculates a subject's eating habit information including at least one of total calories per day, intake nutrient composition ratio, salt intake, omega fatty acid ratio, vitamins and minerals. Here, the eating habit assessment statement may include questions that can identify the total calories consumed, intake nutrient composition ratios, salt intake, omega fatty acid ratio, vitamins or minerals. For example, the eating habit assessment statement may be a food frequency questionnaire (FFQ).

At this time, the eating habit analyzer 160 exposes the subject's eating habit information through the user interface 120 or provides it to the comprehensive evaluator 190.

The symptom evaluator 180 provides at least one type of question among the question for health status test and the question for life habit assessment, receives the response, and obtains the subject symptom information related to the lack of the subject's neurotransmitter or the brain substrate I understand.

Here, the questionnaire for health status questions includes questions that can identify questions related to physical or mental symptoms such as sleep quality, Fatigue Severity Scale, emotional stability (anxiety, depression), cognitive ability, stress level, . At this time, the lifestyle assessment question may include questions that can identify at least one of the amount of alcohol and the amount of exercise.

The EEG analyzer 140 performs Fast Fourier Transform (FFT) on each EEG signal to separate the EEG signals into a plurality of frequencies in the frequency domain, and calculates the EEG power of each subject's frequency.

Here, the plurality of EEG waves may be at least one of a delta wave, a theta wave, an alpha wave, a beta wave and a Kobe beat wave. Hereinafter, for convenience of explanation, a plurality of EEG waves are divided into delta wave, theta wave, , Beta wave, and Kobe beat wave are all included. For example, the EEG power per frequency may be the frequency spectral density (PSD) of the EEG according to the subject's frequency or the average power thereof.

The EEG analyzer 140 compares the power of the subject's delta wave, theta wave, alpha wave, beta wave, and Kobe beat with the reference power of the EEG in the database 200, And generates EEG map information capable of expressing the map.

Specifically, the EEG analyzer 140 measures the power of the delta wave, theta wave, the alpha wave, the beta wave and the kobe beat of the brain of the subject based on the delta wave, theta wave, alpha wave, And the Kobe beat, and generates the brain wave map information capable of expressing the result of the difference operation in the color of the brain wave map for each frequency in a color corresponding to the value. Here, the EEG map information is an EEG-based EEG map, and may be information in which each brain region is coded with a color corresponding to a difference calculation result of the EEG power of the same age. For example, the brain wave analyzer 140 can code based on the standard deviation of brain waves with respect to the age of the subject.

At this time, the EEG analyzer 140 can determine the lack or adequacy of dopamine, serotonin, and GABA, respectively, by using the result of the difference calculation of the subject's theta, alpha and Kobe tap powers, the reference seta waves, have.

For example, the brain wave analyzer 140 determines that the amount of dopamine secretion is insufficient in response to a large degree of theta wave power of the subject if the subject's frontal lobe level power is larger than the reference theta wave power, and if it is the same, can do. Similarly, the brain wave analyzer 140 determines the lack or adequacy of the serotonin secretion amount based on the comparison result between the ALPHA power and the reference ALPHA power, and, based on the comparison result between the Kobe wave power and the reference Kobe beat power, Can be determined.

In addition, the brain wave analyzer 140 can determine the lack or adequacy of acetylcholine using the brain perception time of the subject's ERP brain wave signal. More specifically, if the subject's brain time exceeds the preset reference time, the brain wave analyzer 140 determines that the acetylcholine is deficient according to the degree of the excess, and if the brain perception time is within a predetermined error range , It can be judged that acetylcholine is properly secreted. Here, the reference recognition time may be an average brain-recognition time of a person who is evaluated as having a healthy body and mind.

At this time, the EEG analyzer 140 may transmit the information on the amount of secretion of the respective neurotransmitter to the comprehensive evaluator 190.

The autonomic neuropathic analyzer 130 performs fast Fourier transform of the instantaneous heart rate or heart rate variability and separates and analyzes the power of each frequency band constituting the heart rate variability in the frequency domain. Here, the parameters according to the analysis result include a power of a very low frequency (hereinafter referred to as VLF), a power of a low frequency band (hereinafter referred to as LF), a frequency of a high frequency band Hereinafter referred to as HF) and a 5-minute total power (hereinafter referred to as TP). Here, the power may be the power of the unit frequency of the measurement time of each frequency band or the average power.

At this time, the autonomic neuropathic analyzer 130 calculates LF power and HF power and its ratio (i.e., the ratio of sympathetic and parasympathetic nerves or autonomic balance).

The autonomic neuropathic analyzer 130 compares at least one of the subject's TP power, LF power, and HF power with predetermined reference pulse wave power to determine whether the cardiac flexibility is lowered. At this time, the reference pulse wave power may be different according to the age of the subject. For example, the autonomic nerve analyzer 130 can determine that the subject's cardiac flexibility is lowered if the subject's pulse wave power is below the reference pulse wave power.

The autonomic neuropathic analyzer 130 then generates autonomic information including VLF power, LF power, HF power, TP, LF: HF power ratio, and cardiac flexibility. At this time, the autonomic neuropathic analyzer 190 may generate autonomic information including only the LF power and the HF power and whether the ratio and the cardiac flexibility are lowered.

As shown in FIG. 2, the comprehensive evaluator 190 uses the at least one of the total score information of the brain matrix, the cognitive power information, the subject's eating habit information, the subject's symptom information, the brain wave map information, and the autonomic nerve information, , Eating habit information, symptom information, frequency-based EEG map, and autonomic nervous balance.

At this time, in the evaluation result sheet, the total score information of the brain matrix is displayed in the order of GABA, serotonin, acetylcholine and dopamine (see (9), (35), 8, And can be represented by a two-dimensional brain matrix square having a total score as each vertex (refer to 260 in FIG. 2).

In addition, an EEG map of each frequency can be expressed in graphic form using the EEG map information of the subject in the evaluation result sheet. At this time, the frequency-based EEG map can be a map in which each brain region is blue when the difference between the EEG power of the brain region and the reference power is positive, and 0 if the result is positive (see 210 in FIG.

In addition, the evaluation result may include a graph representing each parameter according to the autonomic nervous balance information, and numerical values of the sympathetic and parasympathetic nerves (see 230 in FIG. 2).

In addition, the evaluation result may include a cognitive table in which at least one cognitive ability tested for the subject among the visual memory, the word memory, and the numerical memory of the subject is distinguished (refer to FIG. 2, 240).

In addition, the evaluation result may include at least one of the daily calorie intake of the subject, the intake nutrient composition ratio, the salt intake amount, and the omega fatty acid information in a character and graphic form using the subject's eating habit information (see 250 in FIG. 2).

On the other hand, although not shown in FIG. 2, the evaluation result may include an acetylcholine brain wave map corresponding to the secretion amount of acetylcholine.

As shown in FIGS. 3A and 3B, the comprehensive evaluator 190 analyzes the subject's brain characteristics, cognitive ability, eating habit information, symptom information, brain wave pattern, autonomic nervous balance, Lt; / RTI >

The comprehensive evaluator 190 may receive a non-pharmacological prescription (a solution for enhancing brain health) capable of enhancing the deficient neurotransmitter of the subject from the database 200 and a non-pharmacological prescription capable of activating the weakened autonomic nerve , An autonomic nervous balance solution), as shown in FIG. 4, for example.

Here, the brain health promotion solution may include non-pharmacological prescriptions such as nutritional supplements such as vitamins and minerals, herbs, spices, tea, foods, and diets that can promote secretion of deficient neurotransmitters.

Accordingly, the recommendation result of the brain health promotion solution may include offline store or site information from which items corresponding to the prescription can be purchased. Specifically, the results of recommending brain health promotion solutions are as follows: ① online shopping malls or offline selling places of vitamins, minerals and the like; ② specific co-productions selling health supplements, herbs, spices, , And (3) information about specific care professionals (doctor, oriental medicine, fitness expert, chiropractic expert, nutrition therapist, etc.) (workplace, etc.).

In addition, the autonomic balance solution may include food, respiratory or chiropractic therapies that can promote weakened autonomic nerves in the sympathetic or parasympathetic nerves. For example, a method of activating the parasympathetic nerve can be to press a finger except the fourth finger of both hands, or to spit out the exhalation.

At this time, the comprehensive evaluator 190 can provide at least one of the evaluation result sheet, the advice sheet, and the brain health promotion solution recommendation result sheet to the subject through the user interface 120 such as a print and display means.

On the other hand, in the above-described example, the case where the deficient neurotransmitter of a subject is judged by using a setapar map, an alfapar map, a Kobe tapa map, a brain perception time or a P300 map corresponding thereto is described as an example. In addition, the brain wave analyzer 140 compares the brain wave power of at least one of the delta wave power and the beta wave power of the subject with the corresponding reference brain wave power, or the peak frequency of at least one brain wave, It is needless to say that it is possible to evaluate the subject's other brain function problems by comparing the dynamic change of the peak frequency or by comparing the connectivity between at least one specific region of the EEG.

In addition, in the above-described embodiment, the case in which the cognitive test, the paperweight test, the EEG test, and the pulse wave test are integrated is described as an example. Alternatively, the brain function evaluation system 10 according to an embodiment of the present invention may perform EEG tests and pulse wave tests when there is a situation requiring precise evaluation of brain waves in at least one of the results of the interview test and the perception test Or may be performed in an advancing manner.

Alternatively, in the above-described embodiment, the comprehensive evaluator 190 generates and provides a non-pharmacological prescription that can facilitate the secretion of the neurotransmitter that is deficient.

It is needless to say that the comprehensive evaluator 190 may also provide a pharmacological prescription that can control the secretion amount of the neurotransmitter and the balance of the autonomic nerve, including the recommendation result of the brain health promotion solution.

Meanwhile, the autonomic neural analyzer 130, the brain wave analyzer 140, the brain matrix estimator 170, the cognitive performance evaluator 150, the eating habit analyzer 160, the symptom evaluator 180, 190 may each include at least one processing unit 1100 and may be each component of at least one processing unit. And may further include a memory according to an embodiment. The processing unit 1110 may include, for example, a central processing unit (CPU), a graphics processing unit (GPU), a microprocessor, an application specific integrated circuit (ASIC), a field programmable gate array And may have a plurality of cores. The memory 1120 can be a volatile memory (e.g., RAM, etc.), a non-volatile memory (e.g., ROM, flash memory, etc.) or a combination thereof.

As described above, one embodiment of the present invention provides a non-pharmacological health (wellness) prescription that can easily determine the deficient neurotransmitter of a subject using EEG for a subject and activate secretion of a deficient neurotransmitter can do.

In addition, one embodiment of the present invention can be used for various purposes in hospitals, school health rooms, nutritional supermarkets such as vitamins, etc., and it is possible to prevent people's mental health from deteriorating so that hospital treatment is indispensable.

In addition, one embodiment of the present invention is to correlate the measurement results of EEG and heart beat variability with the results of the subject's examination to understand the relationship of the subject to deficient neurotransmitters in his or her body and mental symptoms, , Eating habits, and so on.

The brain function evaluation system 10 according to an embodiment of the present invention is configured as one integrated system, and the brain function is evaluated for a target person in proximity to the system. Alternatively, the brain function evaluation system according to an embodiment of the present invention may be configured as a clouding-based system that receives a test such as brain waves of a remote subject, analyzes the same, and provides a prescription for a target person Of course.

Hereinafter, a brain function evaluation system according to another embodiment of the present invention will be described with reference to FIGS. 5 and 6. FIG. FIG. 5 is a block diagram illustrating a brain function evaluation system according to another embodiment of the present invention, and FIG. 6 is a flowchart illustrating a brain function evaluation method according to another embodiment of the present invention.

5, the brain function evaluation system 50 according to another embodiment of the present invention includes a bio-information measuring device 510, an interface terminal 520, and a brain function evaluating device 530. As shown in FIG.

The bio-information measuring device 510 measures the subject's brain waves and pulse waves.

At this time, the bio-information measurer 510 may be configured to include the EEG measuring unit and the autonomic nerve measuring unit as separate apparatuses. Alternatively, the bio-information measurer 510 may include a brain wave measuring unit and an autonomic nerve measuring unit as one device, and may be configured to measure a pulse wave simultaneously with an EEG measurement.

The bio-information measuring device 510 transmits brain function evaluation information including the measured subject's brain wave and pulse wave information and subject information (subject name, age, resident number, etc.) to the brain function evaluation device 530 ). ≪ / RTI >

Alternatively, the tester measuring the EEG and pulse waves may transmit the EEG and pulse wave information measured by the bio-information measuring device 510 to the brain function evaluation device 530 through the wired / wireless interface in association with the subject information at the interface terminal 520, As shown in FIG.

The terminal for interface 520 may be a terminal used for providing a brain function evaluation result and a brain function evaluation result, such as a PC, a portable terminal, a laptop, and the like.

For example, the interface terminal 520 may be a personal computer such as a subject, a doctor, a pharmacist, a health teacher, a portable terminal, a smart phone, a smart pad, or the like, which can communicate with the brain function evaluation device 530 through a wired / wireless interface.

The brain function evaluating apparatus 530 includes an autonomic nerve analyzer 130, an electroencephalograph analyzer 140, a brain matrix estimator 170, a cognitive performance evaluator 150, a food habit analyzer 160, a symptom evaluator 180, An evaluator 190 and a database 200.

The brain function evaluating apparatus 530 communicates with the interface terminal 520 through the wired / wireless interface to analyze the subject's brain wave and pulse wave information and the result of the inquiry, and as a result, Promotion Solution Provide a result sheet containing at least one of the recommended results, the findings, and the evaluation results.

At this time, the brain function evaluating apparatus 530 performs such a function by each of the above-mentioned constituent elements, and each component of the brain function evaluating apparatus 530 performs each function of the brain function evaluating system according to an embodiment of the present invention Elements, and a detailed description thereof will be omitted.

Hereinafter, a brain function evaluation method according to another embodiment of the present invention will be described with reference to FIG.

6, when the interface terminal 520 accesses the brain function evaluation web site (S610), the brain function evaluation apparatus 530 determines whether or not the brain function evaluation apparatus 530 receives the brain structure evaluation statement, the eating habit evaluation statement, The questions to be evaluated are sequentially provided among the questions for habit evaluation, and the responses are received (S620).

In operation S600, the brain function evaluating apparatus 530 performs user authentication through the interface terminal 520, and may provide the user with the item to be interviewed to the interface terminal 520 only.

In addition, the brain function evaluating apparatus 530 provides the interface terminal 520 with a screen for the cognitive test of the subject, receives the response, and tests the cognitive performance of the subject (S630).

Then, the brain function evaluating apparatus 530 analyzes the response according to the questionnaire and the cognitive test result, and generates the result of the interview and the cognitive ability analysis (S640).

Specifically, the brain function evaluating apparatus 530 analyzes the responses of the brain temperament evaluating statements, the eating habit evaluating statements, the health condition examining questions, and the lifestyle questioning questions to determine the brain structure, eating habits, body / Mental symptoms and lifestyle. In addition, the brain function evaluating apparatus 530 can generate the cognitive performance analysis result of the cognitive ability of the subject by comparing the cognitive ability of the subject with the cognitive ability standard value according to the age.

Thereafter, the brain function evaluating apparatus 530 provides the evaluation result of the on-line test including the results of the inquiry and the cognitive analysis to the terminal 520 for interface via a web page or mail (S650).

At this time, the brain function evaluating apparatus 530 may include a question describing the necessity of the EEG and the pulse wave examination if there is a problem in the cognition of the subject, or in a state in which a comprehensive score of the body / It can be included in the result of online inspection.

When the brain function evaluating apparatus 530 receives the brain wave and pulse wave information of the subject (example of S660), the brain function evaluating apparatus 530 analyzes the brain wave and pulse wave information as described in the embodiment of the present invention described above, (Sympathetic nerve and parasympathetic nerve) (S670).

The brain function evaluating apparatus 530 provides at least one of a result report, an evaluation result sheet, and a recommendation result of a brain health promotion solution using the results of analyzing the test results and the cognitive analysis results as a result of analysis of brain wave and pulse wave information (S680) .

As such, another embodiment of the present invention can evaluate the cognition, eating habits, lifestyle and health condition of the subject online and guide the necessity of precise evaluation of brain waves and the like when necessary, May be induced to evaluate brain health.

Thus, another embodiment of the present invention can be used for various purposes in hospitals, school health rooms, nutritional supermarkets such as vitamins, etc., and it is possible to prevent people's mental health from deteriorating so that hospital treatment is indispensable.

In addition, other embodiments of the present invention can provide a non-pharmacological wellness regimen that can easily determine the subject's tribal neurotransmitter and activate secretion of the deficient neurotransmitter.

In another embodiment of the present invention, the measurement result of EEG and heart rate variability is correlated with the cognitive ability or the result of the questionnaire of the subject to understand the relationship between the subject and the deficient neurotransmitter in his or her body and mental symptoms, You can easily induce your behavior, eating habits, and so on.

In addition, the above-described method can be implemented in a recording medium readable by a computer or the like using, for example, software, hardware, or a combination thereof.

According to a hardware implementation, the methods described so far can be applied to various types of application specific integrated circuits (ASICs), digital signal processors (DSPs), digital signal processing devices (DSPDs), programmable logic devices (PLDs), field programmable gate arrays processors, controllers, micro-controllers, microprocessors, and other electronic units for performing other functions.

According to a software implementation, the procedures and functions described herein may be implemented in separate software modules. The software modules may be implemented in software code written in a suitable programming language. The software code may be stored in a memory and executed by a processor.

While the present invention has been described in detail with reference to the accompanying drawings, it is to be understood that the invention is not limited to the above-described embodiments. Those skilled in the art will appreciate that various modifications, Of course, this is possible. Accordingly, the scope of protection of the present invention should not be limited to the above-described embodiments, but should be determined by the description of the following claims.

Claims (17)

A bio-information acquiring unit for acquiring an EEG signal from the brain region of the subject;
An EEG analyzer for comparing EEG information corresponding to the acquired EEG signal with predetermined EEG information to analyze whether there is a deficient neurotransmitter among the neurotransmitters of the subject; And
As a result of the analysis, if there is a deficient neurotransmitter, a solution including a non-pharmacological first prescription capable of controlling the secretion amount of the deficient neurotransmitter,
A brain function evaluation system. 2. The method according to claim 1,
The brain function evaluation system, which is an EEG indicator of a person whose mental body corresponding to the age of the subject is evaluated as healthy. The apparatus according to claim 1,
Serotonin, and Gaba, respectively, by using the difference calculation results of the setter, the alpha wave, and the Kobe beat power according to the obtained EEG signal, the preset reference theta wave, the reference alpha wave, and the reference Kobe beat power,
And determining whether the acetylcholine is deficient or titrated by comparing the brain perception time according to the obtained EEG signal with a preset reference perception time. The method according to claim 1,
A cognitive evaluator for testing at least one of cognitive ability of the subject's visual memory, word memory, and numerical memory; And
Further comprising an article evaluator for reviewing at least one of the subject's brain temperament, eating habits, health status and lifestyle habits,
Wherein the global evaluator generates a recommendation describing associating the at least one cognitive power and the at least one outcome with the deficient neurotransmitter. 5. The document evaluating apparatus according to claim 4,
A dietary habit analyzer that provides a question related to the food consumed by the subject and generates a dietary habit information of the subject including daily total calories, intake nutrient composition ratio, salt intake amount and omega fatty acid ratio using an answer to the question;
A brain matrix estimator for analyzing brain characteristics of the subject using the affirmative and inferior proportions of the neurotransmitter in response to each of the questions for inquiring whether the neurotransmitter has the characteristics of excessive secretion of the neurotransmitters; And
And a symptom evaluator for providing a question related to the health condition and lifestyle and analyzing symptom information of the subject related to the lack or excess of the neurotransmitter using the response. The system according to claim 5,
And generating an evaluation result sheet including brain wave maps classified and displayed as a result of at least one test result among the cognitive ability, the eating habit information, the brain temperament characteristics, and the symptom information of the subject and the deficiency or the titration of each neurotransmitter of the subject Brain function evaluation system. 5. The method of claim 4,
Wherein the cognitive performance evaluator, the paper evaluator, the brain wave analyzer, and the comprehensive evaluator are included in a clouding-based brain function evaluation apparatus,
The brain function evaluating apparatus comprises:
When the terminal capable of being interfaced by the subject through the cognitive evaluator and the paper evaluator accesses a predetermined web page, the interfacing with the terminal tests the at least one cognitive ability,
And analyzing the presence or absence of the deficient neurotransmitter by receiving the EEG signal obtained by the bio-information acquirer through the EEG analyzer and the at least one wired / wireless interface,
And provides the solution recommendation result sheet and the recommendation sheet generated by the comprehensive evaluator to the terminal. The method according to claim 1,
Wherein the bio-information acquiring unit is means for measuring the EEG signal,
Wherein the brain wave analyzer and the comprehensive evaluator are included in a clouding-based brain function evaluation apparatus, wherein the brain function evaluation apparatus receives and analyzes an EEG signal acquired by the bio-information acquirer through a wired / wireless interface, And if so, provides the terminal capable of confirming the solution recommendation result sheet by the subject. The method according to claim 1,
Further comprising an autonomic neuropathic analyzer for analyzing the balance of the sympathetic nerve and the parasympathetic nerve and the activity of the cardiac flexibility from the pulse wave signal of the subject when the bio-information acquirer further comprises a pulse wave acquiring unit for acquiring the pulse wave signal of the subject,
Wherein the comprehensive evaluator generates the solution recommendation result sheet including a non-pharmacological second prescription for activating the weakened autonomic nerve in the sympathetic and parasympathetic nerves. 10. The method of claim 9,
Wherein the bio-information acquiring unit is means for measuring the EEG signal and the pulse wave signal,
The brain wave analyzer and the comprehensive evaluator are included in a brain function evaluation apparatus based on a clouding,
Wherein the brain function evaluating device receives and analyzes an EEG signal and a pulse wave signal obtained by the bio-information acquirer through a wired / wireless interface to check whether the deficient neurotransmitter is present, and if the first and second prescriptions are present, And provides the solution recommendation result including the solution recommendation result to the terminal capable of being confirmed by the target person. The apparatus according to claim 1,
Wherein the at least one EEG power is compared with a reference EEG index corresponding to the at least one EEG power among the delta wave power and the beta wave power according to the obtained EEG signal, A brain function evaluation system in which the dynamic change of the peak frequency is compared with each other or the brain activity of the predetermined region is compared to evaluate the subject's other brain function problems. The method according to claim 1,
An offline selling place where at least one of the health supplement and the food corresponding to the first prescription can be purchased;
An online site where at least one of the health supplement and the food corresponding to the first prescription can be purchased; And
And information regarding at least one of specific care expert information corresponding to the first prescription. A brain function evaluation method using a brain function evaluation apparatus,
Sequentially providing a web page for testing at least one of cognitive ability, brain temperament characteristic, eating habit, health condition, and lifestyle when a terminal capable of being interfaced by a subject is connected online;
Guiding the necessity of precise evaluation of the subject through the terminal if there is a symptom associated with deficiency or excessive secretion of neurotransmitters of the subject as a result of the test through the web page;
Receiving an EEG signal obtained from a brain part of the subject, which has undergone precise evaluation according to the guidance of the guiding step, from a measuring device of the terminal or EEG signal;
Analyzing whether there is a deficient neurotransmitter among the neurotransmitters of the subject by comparing brain wave information corresponding to the brain wave signal with predetermined reference brain wave information; And
The method comprising: generating a solution recommendation result sheet including a non-pharmacological first prescription that can control the secretion amount of the deficient neurotransmitter if the deficient neurotransmitter is present;
Further comprising the steps of: 14. The method of claim 13,
Acquiring the pulse wave signal from a second measuring device for measuring a pulse wave signal of the subject or from the terminal that has received the pulse wave signal from the second measuring device; And
Analyzing the balance of the sympathetic nerve and the parasympathetic nerve and the activity of the cardiac flexibility from the pulse wave signal of the subject,
Wherein providing to the terminal comprises generating the solution recommendation result page that includes a second non-prescription for activating the weakened autonomic nerve in the sympathetic and parasympathetic nerves. 14. The method of claim 13,
Evaluating deficiency or titration of dopamine, serotonin and GABA by using the difference calculation results of the setter wave, the alpha wave and Kobe beat power according to the obtained EEG signal, the preset reference theta wave, the reference alpha wave and the reference Kobe beat power, ; And
Evaluating the lack or titration of acetylcholine by comparing the brain perception time with the reference perceived time according to the acquired EEG signal,
Wherein the brain function evaluation method comprises the steps of: 14. The method of claim 13, wherein the sequentially providing comprises:
Providing a question related to the food consumed by the subject and generating a subject's eating habit information including daily total calories, intake nutrient composition ratio, salt intake amount and omega fatty acid ratio using an answer to the question;
Providing each of the questions corresponding to the personality traits of the neurotransmitters in excess secretion and analyzing the brain trait characteristics of the subject using positive and negative ratios of the neurotransmitters in the response;
Providing a question related to the health condition and lifestyle and analyzing symptom information of a subject related to the lack of the neurotransmitter using the response; And
Generating a sentence describing the brain matrix characteristics, eating habit information, and symptom information in association with the deficient neurotransmitter;
Further comprising the steps of: 17. The method of claim 16,
The method of claim 1, further comprising the step of generating an evaluation result sheet including EEG cognition information, eating habit information, brain characteristics, symptom information, and EEGs classified and displayed as a lack or titration of each neurotransmitter in the subject,
Wherein the step of providing to the terminal comprises the step of providing the recommendation sheet and the evaluation result sheet.

Images